Humana Inc.

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse Other stock markets 01:30:02 20/09/2024 am IST			5-day change	1st Jan Change
312.00 ^USD	-1.04%		-4.93%	-31.85%

17/09	Express Scripts sues FTC over drug pricing report, court documents show	RE
05/09	RBC Raises Price Target on Humana to $400 From $385, Maintains Outperform Rating	MT

Tranche Update on Humana Inc.'s Equity Buyback Plan announced on February 15, 2024.

July 31, 2024 at 11:39 pm IST

From April 1, 2024 to July 30, 2024, the company has repurchased 144,045 shares, representing 0.12% for $47.96 million. With this, the company has completed the repurchase of 1,948,690 shares, representing 1.62% for $749.57 million under the buyback announced on February 15, 2024.

Latest news about Humana Inc.

Express Scripts sues FTC over drug pricing report, court documents show	17/09	RE
RBC Raises Price Target on Humana to $400 From $385, Maintains Outperform Rating	05/09	MT
Analyst recommendations: Booking Holdings, Humana, Dollar Tree, Lloyds Banking Group...	05/09
RBC Adjusts Price Target on Humana to $400 From $385, Maintains Outperform Rating	05/09	MT
Humana Inc. Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 08:00 AM	04/09
Humana, Evergreen Nephrology Launch Kidney Care Program	29/08	MT
Humana Inc. and Evergreen Nephrology Introduce New Specialized Care Program for Patients Living with Kidney Disease	29/08	CI
JPMorgan Adjusts Price Target on Humana to $396 From $332, Maintains Neutral Rating	21/08	MT
Humana Maintains Quarterly Dividend at $0.885 Per Share; Payable Oct. 25 to Shareholders of Record Sept. 30	15/08	MT
The latest transactions by star managers	15/08
Humana Inc. Declares Cash Dividend, Payable on October 25, 2024	15/08	CI
Wells Fargo Raises Humana's Price Target to $387 From $350	14/08	MT
Deutsche Bank Adjusts Humana Price Target to $349 From $341, Maintains Hold Rating	02/08	MT
TD Cowen Cuts Humana's Price Target to $402 From $407	02/08	MT
Cantor Fitzgerald Adjusts Price Target on Humana to $395 From $360	01/08	MT
Jefferies Adjusts Price Target on Humana to $419 From $365	01/08	MT
Barclays Adjusts Price Target on Humana to $364 From $370	01/08	MT
Bernstein Adjusts Price Target on Humana to $405 From $357	01/08	MT
Oppenheimer Adjusts Price Target on Humana to $400 From $370	01/08	MT
Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost	01/08	RE
Equities Rise as Fed Chair Powell Says September Rate Cut 'Could be on The Table'	01/08	MT
Equities Rise After Fed Chair Powell Says September Rate Cut Possible	01/08	MT
Sector Update: Health Care Stocks Softer in Late Afternoon Trading	01/08	MT
Top Midday Decliners	01/08	MT
Tranche Update on Humana Inc.'s Equity Buyback Plan announced on February 15, 2024.	31/07	CI

Chart Humana Inc.

Duration

Period

More charts

Company Profile

Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).

Employees

67,600

Sector

Managed Healthcare

Calendar

30/09/2024 - Détachement de

More about the company